Related Experiment Video

Updated: May 30, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

Patent ductus arteriosus: wait and see?

Federico Schena1, Elena Ciarmoli, Fabio Mosca

  • 1UO Neonatologia e TIN, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy. federico.schena@mangiagalli.it

The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
|August 12, 2011
PubMed

Insights

Patent ductus arteriosus (PDA) treatment in preterm infants remains controversial due to inconclusive evidence. A selective approach, targeting infants most likely to benefit, may be optimal, but further research on long-term outcomes is required.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Clinical Research

Background:

  • Patent ductus arteriosus (PDA) is a frequent complication in preterm infants.
  • Current treatment strategies for PDA lack definitive evidence of efficacy.
  • Inconclusive results from randomized controlled trials and meta-analyses necessitate a re-evaluation of PDA management.

Purpose of the Study:

  • To analyze the evidence supporting and opposing routine treatment of PDA in preterm infants.
  • To evaluate the current therapeutic strategies for PDA.
  • To determine the optimal approach for managing PDA in this vulnerable population.

Main Methods:

  • Systematic review of randomized controlled trials and meta-analyses.
  • Critical analysis of evidence for and against PDA treatment.
  • Evaluation of patient selection criteria for therapeutic intervention.

Main Results:

  • Evidence for routine PDA treatment is inconclusive.
  • A less aggressive approach towards PDA is suggested by some authors.
  • Strict patient selection for treatment is likely a beneficial strategy.

Conclusions:

  • Further research is needed to establish definitive indications for PDA treatment.
  • Long-term outcome studies are crucial for guiding clinical practice.
  • A selective treatment strategy, based on patient benefit, is currently recommended.

More Related Videos

Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model06:04

Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model

Published on: June 9, 2023

The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation09:03

The Perinatal Asphyxiated Lamb Model: A Model for Newborn Resuscitation

Published on: August 15, 2018

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...